Werry, Tim D <br/><br/>
Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: agonist-specific activation pathways and the impact of RNA editing.  [electronic resource] 

 -  Biochemical pharmacology  Nov 2008 
 - 1276-87 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2008.08.024  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>CHO Cells<br/>Cell Line<br/>Chlorocebus aethiops<br/>Cricetinae<br/>Cricetulus<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>Phosphorylation--drug effects<br/>RNA Editing--drug effects<br/>Receptor, Serotonin, 5-HT2C--metabolism<br/>Serotonin 5-HT2 Receptor Agonists<br/>Serotonin Receptor Agonists--pharmacology